Russian government to start limitation of drug imports

1 June 2016
moscow-big

The Russian government will start to limit the participation of foreign drugs in the public procurement and state tenders since the second half of the current year, according to recent statements of Arkady Dvorkovich, Russia’s Deputy Prime Minister.

Mr Dvorkovich said that imported drugs will not be the subject of public procurement in the case of the presence of two or more domestic analogues during the tender process, while the norm will apply only to those drugs from the list of vital medicines.

At the same time the norm will not apply to pharmacies that will continue drug purchases without any limitations.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical